Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ceterizine hydrochloride × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Exanthema 1 Diarrhea 1

Interventions

Specimen Handling 153 Magnetic Resonance Spectroscopy 125 Biopsy 99 pembrolizumab 83 Carboplatin 69 Cyclophosphamide 67 Paclitaxel 57 Cisplatin 54 Nivolumab 49 venetoclax 44 Radiotherapy 38 Gemcitabine 36 fludarabine 33 durvalumab 33 Rituximab 33 Dexamethasone 33 Bevacizumab 33 olaparib 30 atezolizumab 30 Prednisone 29 Oxaliplatin 29 X-Rays 28 Radiation 28 Ipilimumab 27 Cytarabine 27 Fluorouracil 25 Etoposide 25 Docetaxel 25 Doxorubicin 24 Azacitidine 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting

Diarrhea, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡